AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaHumanitiesInformation ScienceHealth Care
Consolidation ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsCytarabineDaunorubicinRemission InductionLeukemia, Myeloid, AcuteIdarubicinAmsacrineCombined Modality TherapyEtoposideMitoxantroneLeukemia, MyeloidTreatment OutcomeDisease-Free SurvivalChemotherapy, AdjuvantTransplantation, AutologousSurvival AnalysisCyclophosphamideDrug Administration SchedulePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Promyelocytic, AcuteAntineoplastic AgentsNeutropeniaMemorySurvival RateAcute DiseaseHematopoietic Stem Cell TransplantationCisplatinFollow-Up StudiesDoxorubicinProspective StudiesRetention (Psychology)FearNeoadjuvant TherapyNeoplasm StagingInduction ChemotherapyPrognosisMethotrexateBreast NeoplasmsTime FactorsConditioning, ClassicalAvoidance LearningMemory, Long-TermLung NeoplasmsAnisomycinSleepLearningCarboplatinConditioning (Psychology)AmygdalaPaclitaxelVinblastineNeoplasm Recurrence, LocalBleomycinAssociation LearningFreezing Reaction, CatalepticAntimetabolites, AntineoplasticIfosfamideTaxoidsMental RecallAnthracyclinesElectroshockDrug Resistance, NeoplasmHippocampusSalvage TherapyOsteogenesis, DistractionHealth Facility MergerLymphoma, Non-HodgkinNeoplasmsMelphalanAntineoplastic Agents, AlkylatingDeoxycytidineOrganoplatinum CompoundsNeoplasm, ResidualOvarian NeoplasmsExtinction, PsychologicalCarcinoma, Non-Small-Cell LungRadiotherapy, AdjuvantThioguanineMaze LearningDose-Response Relationship, DrugRecurrenceChemotherapy, Cancer, Regional PerfusionHodgkin DiseaseWakefulnessNeoplasm MetastasisCarmustineAntibiotics, AntineoplasticAnalysis of VarianceAsparaginaseVindesineKaplan-Meier EstimateClinical Trials as TopicAntineoplastic Agents, PhytogenicMaintenance ChemotherapyRadiotherapyGranulocyte Colony-Stimulating FactorNeuronal PlasticityTesticular NeoplasmsProtein Synthesis Inhibitors

A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia. (25/34)

 (+info)

High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial. (26/34)

 (+info)

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia. (27/34)

 (+info)

Jump-starting the T cells in CLL. (28/34)

 (+info)

Why is it so difficult to use gemtuzumab ozogamicin? (29/34)

 (+info)

Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. Coli. (30/34)

 (+info)

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. (31/34)

 (+info)

Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients  (+info)